T. Yamamoto et al., INCREASE IN EXPERIMENTAL PULMONARY METASTASIS IN MICE BY L-ARGININE UNDER INHIBITION OF NITRIC-OXIDE PRODUCTION BY N-G-NITRO-L-ARGININE METHYL-ESTER, International journal of cancer, 75(1), 1998, pp. 140-144
As we have previously reported, intraperitoneal injections of N-G-nitr
o-L-arginine methyl ester [L-NAME; a competitive inhibitor of nitric o
xide (NO) synthase] before and after the injection of B16 melanoma cel
ls through a tail vein increased experimental pulmonary metastasis, wh
ile simultaneous injections of L-arginine (a substrate of NO synthase)
at a 20-fold higher dose synergistically increased pulmonary metastas
is. Our present study was intended to elucidate the mechanisms by whic
h L-NAME alone or together with L-arginine increases metastasis. injec
tions of L-NAME decreased the serum concentration of nitrite plus nitr
ate (metabolites of NO) by about 50%, which was not reversed by simult
aneous injections of L-arginine. Injections of L-NAME also decreased t
he diameter of arterioles and venules by 20-30%, while simultaneous in
jections of L-arginine did not show any significant effect. When colla
gen- or ADP-induced platelet aggregation was examined using platelet-r
ich plasma, injections of L-NAME showed little effects on platelet agg
regation, while simultaneous injections of L-arginine rather suppresse
d platelet aggregation. B16 melanoma cells produced NO in culture, and
L-NAME (0.2 mM) decreased NO production without effects on viability.
Our results suggest that the increased experimental pulmonary metasta
sis induced by L-NAME can be ascribed partly to the contraction of art
erioles and venules, which is induced by the inhibition of endogenous
NO production by L-NAME, and that the synergistic effect of L-arginine
on metastasis is related to the inhibition of endogenous NO productio
n through unknown mechanisms. (C) 1998 Wiley-Liss, Inc.